Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 1
Submit an article Journal homepage
695
Views
4
CrossRef citations to date
0
Altmetric
Author's View

Immunotherapeutic implications of the immunophenotype of pediatric brain tumors

Andrea M Griesinger Department of Pediatrics; Anschutz Medical Campus; University of Colorado at Denver; Aurora, CO USA; Children’s Hospital Colorado; Aurora, CO USACorrespondence[email protected]
,
Andrew M Donson Department of Pediatrics; Anschutz Medical Campus; University of Colorado at Denver; Aurora, CO USA; Children’s Hospital Colorado; Aurora, CO USA
&
Nicholas K Foreman Department of Pediatrics; Anschutz Medical Campus; University of Colorado at Denver; Aurora, CO USA; Children’s Hospital Colorado; Aurora, CO USA
Article: e27256 | Received 15 Nov 2013, Accepted 18 Nov 2013, Published online: 01 Jan 2014

References

  • Griesinger AM, Birks DK, Donson AM, Amani V, Hoffman LM, Waziri A, Wang M, Handler MH, Foreman NK. Characterization of distinct immunophenotypes across pediatric brain tumor types. J Immunol 2013; 191:4880 - 8; http://dx.doi.org/10.4049/jimmunol.1301966; PMID: 24078694
  • Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, et al, Children’s Oncology Group. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 2010; 363:1324 - 34; http://dx.doi.org/10.1056/NEJMoa0911123; PMID: 20879881
  • Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 2000; 6:443 - 6; http://dx.doi.org/10.1038/74704; PMID: 10742152
  • Donson AM, Birks DK, Barton VN, Wei Q, Kleinschmidt-Demasters BK, Handler MH, Waziri AE, Wang M, Foreman NK. Immune gene and cell enrichment is associated with a good prognosis in ependymoma. J Immunol 2009; 183:7428 - 40; http://dx.doi.org/10.4049/jimmunol.0902811; PMID: 19917695
  • Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005; 23:2346 - 57; http://dx.doi.org/10.1200/JCO.2005.00.240; PMID: 15800326
  • Ardon H, De Vleeschouwer S, Van Calenbergh F, Claes L, Kramm CM, Rutkowski S, Wolff JE, Van Gool SW. Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Pediatr Blood Cancer 2010; 54:519 - 25; PMID: 19852061
  • Caruso R, Wierzbicki V, Marrocco L, Salvati M. Paragangliomas of the cauda equina. Report of one case and review of the literature. J Exp Clin Cancer Res 2006; 25:269 - 75; PMID: 16918140
  • Peres E, Wood GW, Poulik J, Baynes R, Sood S, Abidi MH, Klein J, Bhambhani K, Dansey R, Abella E. High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors. Neuropediatrics 2008; 39:151 - 6; http://dx.doi.org/10.1055/s-0028-1093333; PMID: 18991194
  • Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph RW, Weber JS, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013; 369:134 - 44; http://dx.doi.org/10.1056/NEJMoa1305133; PMID: 23724846
  • Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711 - 23; http://dx.doi.org/10.1056/NEJMoa1003466; PMID: 20525992

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.